Microenvironment involved in FPR1 expression by human glioblastomas

Area of Science:

• Neuroscience
• Immunology
• Oncology

Background:

• Formyl peptide receptor 1 (FPR1) plays a role in glioblastoma (GBM) cell motility.
• Understanding FPR1's role in GBM is crucial for developing targeted therapies.

Purpose of the Study:

• To evaluate FPR1 expression in human GBM.
• To investigate FPR1 activation in GBM cells and its inhibition by CHIPS.
• To explore the influence of the brain microenvironment on FPR1 expression.

Main Methods:

• Immunohistochemistry and quantitative PCR were used to assess FPR1 expression in GBM patient samples.
• U87 GBM cells were used to study FPR1 activation by agonists and inhibition by CHIPS.
• Early passage human Groningen Glioma (GG) cell lines were analyzed for FPR1 expression in vitro and in vivo.

Main Results:

• FPR1 was highly expressed in all 178 human GBM patient samples.
• FPR1 activation in U87 cells increased calcium mobilization, AKT/ERK1/2 phosphorylation, and migration, all inhibited by CHIPS.
• Early passage GG cell lines lacked detectable FPR1 in vitro, but expressed it after implantation in mouse brains.

Conclusions:

• FPR1 is a prevalent and activatable target in human GBM.
• The brain microenvironment appears to regulate FPR1 expression in GBM cells.
• FPR1 represents a potential therapeutic target for glioblastoma.